US Patent Issued to Amenis Bioscience on Feb. 10 for "3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same" (Japanese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,643, issued on Feb. 10, was assigned to Amenis Bioscience Inc (Seoul, South Korea).

"3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same" was invented by Tomoichiro Asano (Higashihiroshima, Japan), Yusuke Nakatsu (Higashihiroshima, Japan), Hisanaka Ito (Hachioji, Japan) and Takayoshi Okabe (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides: a compound represented by the following Formula (I) or a salt thereof, as well as a Pin1 inhibitor, a pharmaceutical composition, a therapeutic or prophylactic agent for inflammatory diseases, a therapeutic or prophylact...